Live Breaking News & Updates on Biomedical Enterprise Program

Stay updated with breaking news from Biomedical enterprise program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avidity Biosciences Announces Changes to its Board of Directors


Avidity Biosciences Announces Changes to its Board of Directors
Tamar Thompson and Jean Kim appointed to Board of Directors replacing Todd Brady and Michael Martin
News provided by
Share this article
Share this article
LA JOLLA, Calif., Jan. 11, 2021 /PRNewswire/ Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOCs
™), today announced the appointment of experienced health policy strategist, Tamar Thompson and recognized healthcare investment partner, Jean Kim, to its Board of Directors, who are replacing Todd Brady and Michael Martin.  Avidity also announced that Troy Wilson has transitioned from Executive Chairman to Chairman.  ....

Stanford University , United States , Juniper Point , La Jolla , Merrill Lynch , Todd Brady , Troy Wilson , Sarah Boyce , Tamar Thompson , Jean Kim , Michael Martin , Amy Conrad , Mike Maclean , Partner At Deerfield Management Company , Bristol Myers Squibb Company , Prnewswire Avidity Biosciences Inc , Public Health , Health Sciences , Biomedical Enterprise Program , Avalere Health , Trident University In Cypress California , Us Government Affairs , Massachusetts Institute Of Technology , Board Of Alexion Charitable Foundation , Alexion Pharmaceuticals Inc , Harvard Business School ,